Venturi Wealth Management LLC Buys 302 Shares of ICU Medical, Inc. (NASDAQ:ICUI)

Venturi Wealth Management LLC increased its stake in ICU Medical, Inc. (NASDAQ:ICUI) by 1,510.0% in the third quarter, HoldingsChannel reports. The fund owned 322 shares of the medical instruments supplier’s stock after purchasing an additional 302 shares during the period. Venturi Wealth Management LLC’s holdings in ICU Medical were worth $59,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. BNP Paribas Financial Markets boosted its position in ICU Medical by 55.3% during the 1st quarter. BNP Paribas Financial Markets now owns 4,552 shares of the medical instruments supplier’s stock valued at $489,000 after buying an additional 1,620 shares during the period. Sei Investments Co. grew its stake in shares of ICU Medical by 52.1% in the first quarter. Sei Investments Co. now owns 28,586 shares of the medical instruments supplier’s stock worth $3,068,000 after purchasing an additional 9,793 shares during the last quarter. Russell Investments Group Ltd. increased its holdings in ICU Medical by 46.4% during the 1st quarter. Russell Investments Group Ltd. now owns 546 shares of the medical instruments supplier’s stock valued at $59,000 after purchasing an additional 173 shares during the period. US Bancorp DE raised its position in ICU Medical by 18.2% during the 1st quarter. US Bancorp DE now owns 3,098 shares of the medical instruments supplier’s stock valued at $332,000 after purchasing an additional 476 shares during the last quarter. Finally, Entropy Technologies LP raised its position in ICU Medical by 74.0% during the 1st quarter. Entropy Technologies LP now owns 4,046 shares of the medical instruments supplier’s stock valued at $434,000 after purchasing an additional 1,721 shares during the last quarter. 96.10% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research firms have recently issued reports on ICUI. Needham & Company LLC reissued a “hold” rating on shares of ICU Medical in a research note on Wednesday. StockNews.com downgraded shares of ICU Medical from a “buy” rating to a “hold” rating in a research report on Tuesday. Raymond James raised their target price on shares of ICU Medical from $158.00 to $190.00 and gave the stock an “outperform” rating in a research report on Thursday, September 12th. Jefferies Financial Group assumed coverage on shares of ICU Medical in a research report on Monday, October 14th. They set a “hold” rating and a $183.00 price target on the stock. Finally, KeyCorp raised their price objective on shares of ICU Medical from $198.00 to $209.00 and gave the stock an “overweight” rating in a report on Wednesday. Three analysts have rated the stock with a hold rating and three have given a buy rating to the company. Based on data from MarketBeat.com, ICU Medical presently has an average rating of “Moderate Buy” and an average target price of $173.00.

Insider Activity at ICU Medical

In other news, CEO Vivek Jain sold 12,000 shares of the stock in a transaction that occurred on Tuesday, October 1st. The shares were sold at an average price of $178.46, for a total transaction of $2,141,520.00. Following the sale, the chief executive officer now owns 104,593 shares in the company, valued at $18,665,666.78. This represents a 10.29 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, VP Daniel Woolson sold 2,502 shares of the business’s stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $163.22, for a total transaction of $408,376.44. Following the completion of the transaction, the vice president now owns 13,107 shares of the company’s stock, valued at approximately $2,139,324.54. The trade was a 16.03 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 38,502 shares of company stock valued at $6,573,496 in the last 90 days. Corporate insiders own 6.70% of the company’s stock.

ICU Medical Stock Down 2.4 %

NASDAQ:ICUI opened at $167.86 on Friday. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.29 and a quick ratio of 1.08. The firm’s 50-day moving average price is $176.43 and its 200-day moving average price is $142.68. The company has a market capitalization of $4.11 billion, a PE ratio of -36.73 and a beta of 0.66. ICU Medical, Inc. has a 1-year low of $82.82 and a 1-year high of $196.26.

ICU Medical (NASDAQ:ICUI) last posted its quarterly earnings data on Tuesday, November 12th. The medical instruments supplier reported $1.23 EPS for the quarter, topping the consensus estimate of $0.88 by $0.35. ICU Medical had a negative net margin of 4.74% and a positive return on equity of 5.05%. The business had revenue of $580.07 million for the quarter, compared to analyst estimates of $574.77 million. On average, equities analysts predict that ICU Medical, Inc. will post 3.81 EPS for the current fiscal year.

ICU Medical Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.